We have located links that may give you full text access.
CASE REPORTS
JOURNAL ARTICLE
Alanine peak in central neurocytomas on proton MR spectroscopy.
Neuroradiology 2007 July
INTRODUCTION: We present three consecutive patients with central neurocytoma in whom proton MRS demonstrated the presence of alanine.
MATERIALS AND METHODS: Three patients in the age range 24 to 30 years underwent MRI and proton MRS using a 1.5-T system. MRS was performed with the multivoxel PRESS sequence. All three patients underwent surgery and the diagnosis of central neurocytoma was established by histopathological examination and immunostaining.
RESULTS: With an echo time of 135 ms glycine, high choline, small NAA and alanine were observed in all three patients.
CONCLUSION: Alanine may be observed in central neurocytomas as it is in meningiomas. Other spectral peaks such as those for glycine and NAA should help to identify this tumor correctly.
MATERIALS AND METHODS: Three patients in the age range 24 to 30 years underwent MRI and proton MRS using a 1.5-T system. MRS was performed with the multivoxel PRESS sequence. All three patients underwent surgery and the diagnosis of central neurocytoma was established by histopathological examination and immunostaining.
RESULTS: With an echo time of 135 ms glycine, high choline, small NAA and alanine were observed in all three patients.
CONCLUSION: Alanine may be observed in central neurocytomas as it is in meningiomas. Other spectral peaks such as those for glycine and NAA should help to identify this tumor correctly.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app